Table 2. OS based on sociodemographic and clinical characteristics.
| S. no | Status | Number | 1 year (%) | 3 years (%) | 5 years (%) | p value |
|---|---|---|---|---|---|---|
| OS | 1,895 | 86 | 73 | 65 | ||
| 1. | Age (in years) | 0.36 | ||||
| <40 | 535 | 87 | 72 | 69 | ||
| 41–60 | 1,043 | 85 | 72 | 65 | ||
| >60 | 317 | 88 | 75 | 60 | ||
| 2. | Gender | 0.89 | ||||
| Male | 1,549 | 86 | 73 | 65 | ||
| Female | 346 | 87 | 73 | 66 | ||
| 3. | Primary site (ICD-10) | 0.55 | ||||
| Tongue (C02.9) | 697 | 88 | 73 | 67 | ||
| Gum and alveolus (C03.9) | 246 | 84 | 73 | 61 | ||
| Mouth (04.9) | 180 | 90 | 73 | 65 | ||
| Hard palate (05.0) | 39 | 78 | 66 | 62 | ||
| Buccal mucosa (C06.0) | 675 | 84 | 72 | 66 | ||
| Retromolar area (C06.2) | 51 | 88 | 69 | 47 | ||
| 4. | Histology grade | <0.001 | ||||
| Well-differentiated | 226 | 93 | 85 | 79 | ||
| Moderately differentiated |
860 | 89 | 74 | 65 | ||
| Poorly-differentiated | 263 | 85 | 66 | 58 | ||
| Undifferentiated | 546 | 78 | 62 | 55 | ||
| 5. | TNM stage | <0.001 | ||||
| Stage I | 213 | 98 | 89 | 83 | ||
| Stage II | 262 | 90 | 87 | 80 | ||
| Stage III | 241 | 91 | 76 | 70 | ||
| Stage IV | 951 | 82 | 65 | 55 | ||
| 6. | Intent of treatment | <0.001 | ||||
| Curative | 1,756 | 88 | 75 | 68 | ||
| Palliative | 139 | 52 | 16 | 11 | ||
| 7. | Treatment completion | <0.001 | ||||
| Complete treatment | 1,658 | 88 | 75 | 67 | ||
| Partial treatment | 237 | 71 | 48 | 43 | ||
| 8. | Treatment type | <0.001 | ||||
| Surgery | 534 | 95 | 79 | 74 | ||
| Radiotherapy | 68 | 72 | 62 | 58 | ||
| Chemotherapy | 258 | 51 | 22 | 7 | ||
| Surgery + radiotherapy | 469 | 94 | 86 | 78 | ||
| Chemo + radiotherapy | 95 | 72 | 47 | 38 | ||
| Surgery + chemotherapy | 20 | 70 | 56 | 21 | ||
| Surgery + chemo + radiotherapy | 451 | 89 | 73 | 64 | ||